The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Persistence of Viremia and the Importance of Long–Term Follow–Up After Acute Hepatitis C Infection
Open accessAbstract
The purpose of this investigation was to prospectively characterize acute hepatitis C virus (HCV) infections and to evaluate the hypothesis that the outcome is affected by identifiable clinical or viral factors. One hundred forty–two people with a history of illicit drug use who were HCV antibody-negative in 1988 were followed semiannually through 1996. HCV seroconversion (second generation enzyme immunoassay and recombinant immunoblot assay) was recognized in 43 (30%) of the participants, who were followed up for a median of 72 months. HCV RNA was detected and quantified by polymerase chain reaction in a median of 10 specimens per participant and showed two distinct patterns of viremia: viral clearance was noted in 6 (14%) of the participants, and viral persistence was observed in 37 (86%) of the participants. Subjects with viral clearance were more likely to be white (P = .004), have jaundice (P = .03), and have lower peak viral titer (P = .003). However, the outcome for a given person could not be predicted by clinical features, RNA level, or HCV subtype (as ascertained by analysis of core–E1 complementary DNA sequence). No acute infections were recognized by health care providers. At the time of seroconversion, HCV RNA was detectable in 81% of participants, and recombinant immunoblot assay (RIBA) was positive in 85% of participants. We conclude that approximately 85% of people with acute hepatitis C develop persistent viremia. However, acute infections are uncommonly recognized clinically, underscoring the importance of screening individuals at risk. Long–term follow–up, but no single laboratory test, is necessary to ascertain the outcome and in some cases make the diagnosis of acute HCV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
The Natural History of Community-Acquired Hepatitis C in the United States
Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., Sampliner, R. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272702 · Cited by 1,592
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes
Bukh, J., Miller, R., & Purcell, R. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007262 · Cited by 833
McMahon, B. J., Alward, W. L. M., Hall, D. B., Heyward, W. L., Bender, T. R., Francis, D. P., & Maynard, J. E. (1985) · Journal of Infectious Diseases · doi:10.1093/infdis/151.4.599 · Cited by 832
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
Missale, G., Bertoni, R., Lamonaca, V, Valli, A., Massari, M., Mori, C., Rumi, M. G., Houghton, M., Fiaccadori, F., & Ferrari, C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118842 · Cited by 658
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.
Farci, P., Alter, H. J., Wong, D., Miller, R. H., Shih, J. W., Jett, B., & Purcell, R. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107113250205 · Cited by 571
(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 569
Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., Kilani, A., Areias, J., Auperin, A., Benhamou, J. P., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00003 · Cited by 559
Hepatitis C Virus Type 1b (II) Infection in France and Italy
Nousbaum, J.-B., Pol, S., Nalpas, B., Landais, P., Berthelot, P., Brechot, C., & and The Collaborative Study Group* (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-3-199502010-00001 · Cited by 489
Evaluation of Antibodies to Hepatitis C Virus in a Study of Transfusion-Associated Hepatitis
Esteban, J. I., González, A., Hernández, J. M., Viladomiu, L., Sánchez, C., López-Talavera, J. C., Lucea, D., Martin-Vega, C., Vidal, X., Esteban, R., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010183231605 · Cited by 383
Vlahov, D., US Department of Health and Human Services; National Institute on Drug Abuse, Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., & Polk, B. F. (1991) · PsycEXTRA Dataset · doi:10.1037/e496262006-006 · Cited by 336
Self-citationLong-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
Tremolada, F., Casarin, C., Alberti, A., Drago, C., Tagger, A., Ribero, M. L., & Realdi, G. (1992) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80657-9 · Cited by 263
Shakil, A. O., Conry-Cantilena, C., Alter, H. J., Hayashi, P., Kleiner, D. E., Tedeschi, V., Krawczynski, K., Conjeevaram, H. S., Sallie, R., Bisceglie, A. M. D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00002 · Cited by 254
Thomas, D. L., Zenilman, J. M., Alter, H. J., Shih, J. W., Galai, N., Carella, A. V., & Quinn, T. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.4.768 · Cited by 244
Self-citationIncidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., & Thomas, D. L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.12.3274-3277.1997 · Cited by 227
Self-citationGARSON, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92487-3 · Cited by 217
Therapy of hepatitis C: Overview
Lindsay, K. L. (1997) · Hepatology · doi:10.1002/hep.510260713 · Cited by 211
Gretch, D., Corey, L., Wilson, J., dela Rosa, C., Willson, R., Carithers, R., Busch, M., Hart, J., Sayers, M., & Han, J. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.6.1219 · Cited by 210
Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C
Barrera, J. M., Bruguera, M., Ercilla, G. M., Gil, C., Celis, R., Gil, P. M., Del Onorato, V. M., Rodés, J., & Ordinas, A. (1995) · Hepatology · doi:10.1002/hep.1840210306 · Cited by 185
Early events in hepatitis C virus infection of chimpanzees.
Shimizu, Y. K., Weiner, A. J., Rosenblatt, J., Wong, D. C., Shapiro, M., Popkin, T., Houghton, M., Alter, H. J., & Purcell, R. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6441 · Cited by 167
Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA
Halfon, P., Khiri, H., Gérolami, V., Bourlière, M., Feryn, J. M., Reynier, P., Gauthier, A., & Cartouzou, G. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80116-4 · Cited by 129
Mattsson, L., Sönnerborg, A. B., & Weiland, O. (1993) · Liver International · doi:10.1111/j.1600-0676.1993.tb00644.x · Cited by 108
Couroucé, A. M., Marrec, N. L., Girault, A., Ducamp, S., & SIMON, N. (1994) · Transfusion · doi:10.1046/j.1537-2995.1994.34994378281.x · Cited by 97
Haydon, G. H., Jarvis, L. M., Blair, C. S., et al. (1998) · Gut · doi:10.1136/gut.42.4.570 · Cited by 90
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays
Roth, W. K., Lee, J. H., Rüster, B., & Zeuzem, S. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.2.261-264.1996 · Cited by 76
Marcellin, P., Martinot-Peignoux, M., Elias, A., Branger, M., Courtois, F., Level, R., Erlinger, S., & Benhamou, J. P. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.2.433 · Cited by 63
Patterns and Prevalence of Hepatitis C Virus Infection in Posttransfusion Non-A, Non-B Hepatitis
Prince, A. M., Brotman, B., Inchauspé, G., Pascual, D., Nasoff, M. S., Hosein, B., & Wang, C. Y. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1296 · Cited by 36
Evaluation of two methods for quantitation of hepatitis C virus RNA*, **
Hadziyannis, E. S., FRIED, M., & Nolte, F. S. (1997) · Molecular Diagnosis · doi:10.1016/s1084-8592(97)80009-4 · Cited by 17
Cited by
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Self-citationGenetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150
Self-citationDiagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Self-citationNatural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Panel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Metadata
- Authors
- Villano, S. A., Vlahov, D., Nelson, K. E., Cohn, S., & Thomas, D. L.
- Venue
- Hepatology
- Published
- 1999-03
- Volume
- 29
- Issue
- 3
- Pages
- 908-914
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2027853774
- Cited by
- 475
- References
- 30
- FWCI
- 14.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.